How do governments regulate AI compared with other industries?
AI rules are mostly a risk-based layer added on top of existing industry rules, not one single licensing system.
Covers: This page compares the main approaches governments use to regulate AI — such as voluntary frameworks, risk-based rules, and sector-specific guidance — with established regulatory models in industries like pharmaceuticals, finance, aviation, and food safety. It covers the structure and enforcement of these regimes, not predictions about specific future laws or advice on compliance.
Also answers: How is AI regulated compared to other industries? · AI regulation vs other industries · Are governments regulating AI like they regulate drugs and finance? · Comparing AI regulation with traditional industry regulation
- One page for this question6 other ways of asking lead here
- 7 independent sourcesEvery claim links to what supports it
- 1 connected page1 changed this week
- Clean discussionScreened before anything appears
The short answer
Interpretation AI-prepared starting mapAI regulation is being built mostly as a horizontal, risk-based overlay on top of existing sector rules, rather than as a single licensing regime like those for pharmaceuticals or aviation. The EU adopted a common legal framework for AI with the AI Act in 2024, and since 2016 numerous AI ethics guidelines have been published by bodies including the IEEE…12
Read the full explanation and caveatsAt a glance
What this page stands on
Live · updated just now
The evidence behind it
7 sources- Other studies and data4
- Background3
Published in 2026
| Source | Kind | Year |
|---|---|---|
| Algorithmic governance at work: a legal-sociological and policy analysis of AI regulation, institutional power and labor rights. | Other studies and data | 2026 |
| AI is less regulated than milk, says Microsoft president | Background | 2026 |
| High-risk without safeguards? The EU AI Act and the push for deregulation of medical AI. | Other studies and data | 2026 |
| Governing AI for Mental Health: Fragmented State Approaches and the Case for a Federal Framework. | Other studies and data | 2026 |
| When hospitals build their own AI: a comparison of the EU and US regulatory framework. | Other studies and data | 2026 |
| Regulation of artificial intelligence (Wikipedia) | Background | Unknown |
| Regulation of artificial intelligence in the United States (Wikipedia) | Background | Unknown |
The community around it
No one has added to this page yet. Firsthand experience, a newer study or a different reading of the numbers would show up here, credited to you.
Did this answer your question?
Be the first to voteIn brief
The EU adopted a common legal framework for AI with the AI Act in 2024, while international AI ethics guidelines from bodies such as the IEEE and OECD carry no direct enforcement power.1
Evidence-backedUS AI regulation is split between shifting federal executive orders and a growing set of state laws, with the December 2025 order directing agencies to challenge conflicting state laws and condition some funding on compliance.2
Evidence-backedIn medical AI, proposed EU reforms would keep the high-risk label but strip most AI Act obligations, decoupling risk classification from the safeguards that give it meaning.3
Evidence-backedThe EU treats hospitals developing AI as regulated innovators with defined obligations, while the US lets such innovation emerge as a by-product of general software regulation.4
Evidence-backed
How do you think AI should be regulated compared with other industries?
Join free to voteAlready a member? Sign inYour individual answer is private. Only totals are shown.
Your turn
Have your say
See where others stand. Join free to add your perspective. One answer per account.
How do you feel about this?
No votes yetQuick questions from connected pages
What it means for you
Which fits you?
Pick the situation closest to yours. Each answer says what it rests on.
If you want to know what AI rules actually require of a developer or deployer
look at the sector rules that already apply to the product — for medical AI, the sources describe product-focused medical device law as the centre of gravity, with AI Act obligations potentially removed for high-risk devices.3
Evidence-backedIf you are deploying AI in a workplace
the frameworks described emphasise transparency, non-discrimination and human oversight in AI-powered workplace decisions, alongside data privacy and civil liability questions affecting employee rights.5
Evidence-backedIf you operate in the United States across several states
expect uneven protections and regulatory uncertainty, because states have taken different approaches — some regulating clinical use, some the technology itself — and federal policy has shifted between administrations.62
Evidence-backedIf you are a hospital building your own AI tools
the EU path treats you as a regulated innovator with defined institutional obligations, while the US path is more permissive and less institutionally differentiated.4
Evidence-backedIf you are looking for international rules with enforcement power
the sources describe international bodies such as the IEEE and OECD as lacking direct enforcement power, so binding rules sit at EU, national or state level.1
Evidence-backedIf you are assessing claims that AI is barely regulated
treat such statements as advocacy positions rather than measurements; the comparison to milk comes from a company executive calling for global AI rules, and no compliance-cost or enforcement data appears in these sources.7
InterpretationThe full explanation
Interpretation AI-prepared starting mapAI regulation is being built mostly as a horizontal, risk-based overlay on top of existing sector rules, rather than as a single licensing regime like those for pharmaceuticals or aviation. The EU adopted a common legal framework for AI with the AI Act in 2024, and since 2016 numerous AI ethics guidelines have been published by bodies including the IEEE and OECD, which lack direct enforcement power. In the United States, regulation is split between federal executive orders and agency-level sector rules and a growing set of state laws, with federal policy shifting direction between administrations. The recurring design questions are who is accountable, what is governed, when in the development lifecycle governance applies, and how it is implemented.12
- Evidence 16
- Interpretation 4
The full story · 2 chapters
01
How AI is currently regulated
AI summary:AI rules are emerging worldwide as ethics guidelines, the EU AI Act, and shifting US federal and state measures.
Evidence-backed: AI regulation is described as the development of public sector policies and laws for promoting and regulating AI, and it is an emerging issue in jurisdictions worldwide, including for international organisations without direct enforcement power such as the IEEE and the OECD. Since 2016, numerous AI ethics guidelines have been published in order to maintain social control over the technology, and organisations deploying AI are expected to adhere to established principles and take accountability for mitigating risks. The EU adopted a common legal framework for AI with the AI Act in 2024. AI governance is defined in a 2025 systematic literature review as covering who is accountable for AI systems, what elements are governed, when governance occurs within the development lifecycle, and how it is implemented through frameworks, tools or models.1
Evidence-backed: Across Europe, the Americas and the Asia-Pacific, AI regulation is increasingly organised around six dimensions: protection of human rights and data privacy in the workplace; governance frameworks addressing reskilling, job transformation and adaptation to AI-driven work models; risk-based oversight of AI systems; AI civil liability regimes affecting employee rights and HR practices; promotion of ethical AI to foster trust and mitigate bias; and strengthened monitoring, accountability and non-discrimination mechanisms. Legal frameworks emphasise transparency, non-discrimination and the need for human oversight in AI-powered workplace decisions.5
Evidence-backed: In the United States, the federal government and state governments have developed some regulation of AI through executive orders, federal laws and state laws, and federal agencies have developed some sector-specific regulations related to AI. The Biden administration's October 2023 Executive Order 14110 set directives on AI development and deployment; President Trump revoked it in January 2025 and issued Executive Order 14179. In December 2025, Executive Order 14365 directed federal agencies to develop a unified national approach to AI policy, evaluate state AI laws for potential conflicts, challenge them through legal action, and condition certain federal funding on state compliance, while exempting state laws on child safety, data centre infrastructure and state government procurement. Congress passed the TAKE IT DOWN Act in 2025 targeting AI-generated deepfakes, and several states have enacted AI-related laws, some already in effect, including in California.2
Evidence-backed: A four-state case analysis of statutory text in Illinois, Utah, New York and Nevada identified two governance approaches to AI in mental health: one regulating the use of AI in clinical contexts, and one regulating the technology itself. Some states combine elements of both. The approaches differ in where they locate risk in the use of AI for mental health support, and their limitations include uneven protections for consumers and regulatory uncertainty for developers, vendors, deployers and clinicians. Because AI in mental health operates across both clinical and consumer domains, the analysis argues neither approach alone can address the associated risks, and calls for a coordinated, risk-based federal regulatory floor.6
02
How this compares with medicines, devices and other regulated industries
AI summary:Unlike medicines and devices, AI rules layer oversight obligations over sector rules, with uneven enforcement.
Evidence-backed: The clearest structural contrast in the material is with product-focused regimes. Under the EU simplification agenda, proposed reforms to the Health Innovation Package would retain the high-risk classification of AI-enabled medical devices while removing most associated AI Act obligations. That decouples risk classification from the safeguards that give it regulatory meaning, including requirements on data governance, risk management, human oversight and postmarket monitoring. Rather than resolving regulatory overlap, the amendments shift the centre of gravity back to product-focused medical device law without ensuring equivalent AI-specific safeguards, which the authors argue may narrow attention to fundamental rights, weaken oversight in clinical use and increase legal uncertainty about accountability and responsibility.3
Evidence-backed: A second contrast concerns who is regulated. Hospitals are shifting from passive purchasers of AI systems to active developers of in-hospital machine learning tools tailored to local clinical needs. Comparing how the EU and the USA regulate in-hospital-developed AI-based medical devices across responsiveness to clinical need, distribution of innovative capacity, and pathways for scaling and diffusion, the EU adopts a structured model that treats hospitals as regulated innovators operating under defined institutional obligations, whereas the USA relies on a more permissive and less institutionally differentiated framework in which hospital innovation emerges as a by-product of general software regulation.4
Evidence-backed: A widely reported framing of the gap comes from industry rather than research: Microsoft's president described AI as less regulated than milk and called for global rules on AI, saying the UK is in the best position to lead the charge. This is a claim by a company executive about relative regulatory burden, not a measurement of it.7
Interpretation: Read together, the sources suggest the distinctive feature of AI regulation is not that it is absent but that it is layered: horizontal principles and risk categories sit above sector rules written for other products, and the two layers can pull in different directions. Where medicines and medical devices are governed through pre-market approval tied to a specific product, AI governance as described here is organised around accountability, oversight and monitoring obligations that apply across many products and workplaces, with enforcement power varying sharply between international guidelines and national or state law.134
Before you go
What to remember
The few things worth keeping from this page.
AI regulation is mostly a horizontal, risk-based layer added on top of existing sector rules, not a single licensing regime like those for medicines or aviation.
The EU adopted a common legal framework for AI with the AI Act in 2024, while international AI ethics guidelines from bodies such as the IEEE and OECD carry no direct enforcement power.
US AI regulation is split between shifting federal executive orders and a growing set of state laws, with the December 2025 order directing agencies to challenge conflicting state laws and condition some funding on compliance.
Your reading
0 of 2 chaptersThis answer keeps changing
When new evidence or a better source comes in, this page is updated (it's on version 2, last changed 1 hour ago). Follow it to be told when that happens.
Ask this Sylo
Still wondering about something?
Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.
More on AI
Everything on AI ›How is AI regulated compared with other industries?
How does the regulation of artificial intelligence compare with how other industries are regulated?
How are AI agents audited when they take real-world actions?
How do AI agents take real-world actions and how are they audited?
How does AI change translation work and when are human translators still needed?
What is the evidence on AI use in job applications and hiring?
What does the research evidence show about the use of AI in job applications and hiring processes?
How does AI regulation compare with food and product safety rules?
Behind this page
Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.
Discussion
Sources
Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.
- 1Regulation of artificial intelligence (Wikipedia)WikipediaPublished Oct 12, 2026Checked Oct 14, 2026
“Regulation of artificial intelligence is the development of public sector policies and laws for promoting and regulating artificial intelligence (AI). The regulatory and policy landscape for AI is an emerging issue in jurisdictions worldwide, including for international organizations without direct enforcement power like the IEEE or the OECD. Since 2016, numerous AI ethics guidelines have been published in order to maintain social control over the technology. Furthermore, organizations deploying AI have a central role to play in creating and implementing trustworthy AI, adhering to established principles, and taking accountability for mitigating risks. The European Union adopted in 2024 a common legal framework for AI with the AI Act. AI governance is a term used in policy, industry, and academic contexts to describe how AI systems are directed and overseen. A 2025 systematic literature review defined it as encompassing the questions of who is accountable for AI systems, what elements are governed, when governance occurs within the development lifecycle, and how it is implemented through frameworks, tools, or models.”
- 2Regulation of artificial intelligence in the United States (Wikipedia)WikipediaPublished Oct 12, 2026Checked Oct 14, 2026
“The United States federal government and state governments have developed some regulation of artificial intelligence, including executive orders, federal laws, and state laws. Federal agencies have also developed some sector-specific regulations related to AI. At the federal level, the Biden administration released an October 2023 executive order about AI safety and security, Executive Order 14110, with directives related to AI development and deployment. President Trump revoked that executive order in January 2025 and issued Executive Order 14179. In December 2025, President Trump signed Executive Order 14365, an executive order directing federal agencies to develop a unified national approach to AI policy, evaluate state AI laws for potential conflicts, challenge them through legal action, and condition certain federal funding on state compliance, while exempting state laws related to child safety, data center infrastructure, and state government procurement. In 2025, Congress passed legislation targeting AI-generated deepfakes, the TAKE IT DOWN Act. Several U.S. states have enacted laws related to artificial intelligence. Some are already in effect, including in California.”
- 3High-risk without safeguards? The EU AI Act and the push for deregulation of medical AI.BMJ digital health & AI (Van et al.)Published Sep 30, 2026Checked Oct 14, 2026
“This narrative review analyses the Health Innovation Package and related legislative developments under the EU simplification agenda and examines their impact on the relationship between the AI Act and medical device law. It shows that the proposed reform would retain the high-risk classification of AI-enabled medical devices while removing most associated AI Act obligations. In effect, this decouples risk classification from the safeguards that give it regulatory meaning, including requirements on data governance, risk management, human oversight and postmarket monitoring. Rather than resolving regulatory overlap, the amendments shift the centre of gravity back to product-focused medical device law without ensuring equivalent AI-specific safeguards. These changes may narrow attention to fundamental rights, weaken oversight in clinical use and increase legal uncertainty regarding accountability and responsibility. In a domain where AI systems directly shape clinical decisions and patient outcomes, these changes risk undermining the conditions for safe, equitable and accountable deployment of medical AI.”
- 4When hospitals build their own AI: a comparison of the EU and US regulatory framework.BMJ digital health & AI (Palmieri et al.)Published Sep 17, 2026Checked Oct 14, 2026
“Hospitals are increasingly shifting from being passive purchasers of artificial intelligence (AI) systems to active developers of medical AI, particularly in the form of in-hospital machine learning tools tailored to local clinical needs. This paper examines how the European Union (EU) and the USA regulate in-hospital-developed AI-based medical devices, focusing on the legal and institutional conditions that shape innovation, oversight and diffusion. Through a comparative analysis across three dimensions-responsiveness to clinical need, distribution of innovative capacity and pathways for scaling and diffusion-the paper shows that both systems enable hospital-based innovation but embed it in different regulatory logics. The EU adopts a structured model that treats hospitals as regulated innovators operating under defined institutional obligations, whereas the USA relies on a more permissive and less institutionally differentiated framework in which hospital innovation emerges as a by-product of general software regulation.”
- 5Algorithmic governance at work: a legal-sociological and policy analysis of AI regulation, institutional power and labor rights.Frontiers in sociology (Olimid et al.)Published Aug 19, 2026Checked Oct 14, 2026
“The results indicate that AI regulation across Europe, the Americas, and the Asia-Pacific is increasingly intersecting around human rights and personal data protection, risk-based governance, and accountability mechanisms, particularly in the employment environment. Legal frameworks emphasize transparency, non-discrimination, and the need for human oversight in AI-powered workplace decisions.ConclusionThe conclusions highlight that across Europe, the Americas and the Asia-Pacific, AI regulation is increasingly organized around six dimensions: protection of human rights and data privacy in the workplace; governance frameworks addressing reskilling, job transformation and adaptation to AI-driven work models; risk-based oversight of AI systems; AI civil liability regimes affecting employee rights and HR practices; promotion of ethical AI to foster trust and mitigate bias; and strengthened monitoring, accountability and non-discrimination mechanisms.”
- 6Governing AI for Mental Health: Fragmented State Approaches and the Case for a Federal Framework.JMIR mental health (Aldhalimi)Published Jul 28, 2026Checked Oct 14, 2026
“This Viewpoint aims to identify the governance approaches that US states are using to regulate the use of AI in mental health and analyze the limitations of each. A 4-state case analysis was conducted using the statutory text of bills and laws in Illinois, Utah, New York, and Nevada. Two governance approaches were identified. The first regulates the use of AI in clinical contexts, and the second regulates the technology itself. Some states have combined elements of both approaches to address AI use more comprehensively. While these approaches aim to mitigate harm, they differ in where they believe risk lies in the use of AI for mental health support. The limitations of these divergent approaches include uneven protections for consumers and regulatory uncertainty for developers, vendors, deployers, and clinicians. Because AI in mental health operates across both clinical and consumer domains, neither approach alone can address the risks associated with its use for mental health support. A coordinated, risk-based federal regulatory floor is needed to ensure consistent protections across states.”
- 7AI is less regulated than milk, says Microsoft presidentBBC NewsPublished Oct 12, 2026Checked Oct 14, 2026
“Brad Smith calls for global rules on AI, and says the UK is in the "best position" to lead the charge.”
How it changed
Published 1 time since Oct 14, 2026.
- Version 2Oct 14, 2026Live now
AI-prepared Starting Map from live research.
- First published version.
Help improve it
The brief is open about what's uncertain. These are the specific gaps that new material would fill.
Open questions
What enforcement actually looks like in practice — penalties, inspections, approvals or compliance costs — for AI compared with pharmaceuticals, finance, aviation and food safety is not covered by the available sources.
No answers yet
How the December 2025 US executive order's review and legal challenge of state AI laws will interact with existing state statutes, and whether a federal floor emerges, remains unresolved.
No answers yet
Whether the proposed EU amendments removing most AI Act obligations from high-risk medical AI are adopted, and whether medical device law alone provides equivalent safeguards, is still open.
No answers yet
Comparisons here rest on health care, workplace and mental health examples; how AI rules interact with finance, aviation or food safety regimes is not documented in these sources.
No answers yet
Around this topic
Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.